Back to Search
Start Over
Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
Details
- Database :
- OAIster
- Notes :
- doi:10.1080/2162402X.2018.1433516
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1482515380
- Document Type :
- Electronic Resource
- Full Text :
- https://doi.org/10.1080.2162402X.2018.1433516